Multilocus loss of DNA methylation in individuals with mutations in the histone H3 Lysine 4 Demethylase KDM5C
Authors:
- Daria GrafodatskayaDGDaria Grafodatskaya
- Barian Hy ChungBCBarian Hy Chung
- Darci T ButcherDBDarci T Butcher
- Andrei L TurinskyATAndrei L Turinsky
- Sarah J GoodmanSGSarah J Goodman
- Sana ChoufaniSCSana Choufani
- Yi-An ChenYCYi-An Chen
- Youliang LouYLYouliang Lou
- Chunhua ZhaoCZChunhua Zhao
- Rageen RajendramRRRageen Rajendram
- Fatima E AbidiFAFatima E Abidi
- Cindy SkinnerCSCindy Skinner
Open Access
- 28 January 2013
- journal article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 6 (1) , 1
Abstract
Background: A number of neurodevelopmental syndromes are caused by mutations in genes encoding proteins that normally function in epigenetic regulation. Identification of epigenetic alterations occurring in these disorders could shed light on molecular pathways relevant to neurodevelopment. Results: Using a genome-wide approach, we identified genes with significant loss of DNA methylation in blood of males with intellectual disability and mutations in the X-linked KDM5C gene, encoding a histone H3 lysine 4 demethylase, in comparison to age/sex matched controls. Loss of DNA methylation in such individuals is consistent with known interactions between DNA methylation and H3 lysine 4 methylation. Further, loss of DNA methylation at the promoters of the three top candidate genes FBXL5, SCMH1, CACYBP was not observed in more than 900 population controls. We also found that DNA methylation at these three genes in blood correlated with dosage of KDM5C and its Y-linked homologue KDM5D. In addition, parallel sex-specific DNA methylation profiles in brain samples from control males and females were observed at FBXL5 and CACYBP. Conclusions: We have, for the first time, identified epigenetic alterations in patient samples carrying a mutation in a gene involved in the regulation of histone modifications. These data support the concept that DNA methylation and H3 lysine 4 methylation are functionally interdependent. The data provide new insights into the molecular pathogenesis of intellectual disability. Further, our data suggest that some DNA methylation marks identified in blood can serve as biomarkers of epigenetic status in the brain.Keywords
This publication has 88 references indexed in Scilit:
- Protein degradation and iron homeostasisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- A novel c.2T > C mutation of the KDM5C/JARID1C gene in one large family with X-linked intellectual disabilityEuropean Journal of Medical Genetics, 2012
- Combinatorial Patterning of Chromatin Regulators Uncovered by Genome-wide Location Analysis in Human CellsCell, 2011
- Sequence overlap between autosomal and sex-linked probes on the Illumina HumanMethylation27 microarrayGenomics, 2011
- Reversible histone methylation regulates brain gene expression and behaviorHormones and Behavior, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- The genetic basis of non-syndromic intellectual disability: a reviewJournal of Neurodevelopmental Disorders, 2010
- Genetic Control of Individual Differences in Gene-Specific Methylation in Human BrainThe American Journal of Human Genetics, 2010
- Identification and characterization of two novel JARID1C mutations: suggestion of an emerging genotype–phenotype correlationEuropean Journal of Human Genetics, 2009
- MAP'ing CNS Development and Cognition: An ERKsome ProcessNeuron, 2009